United States: Consumer Protection

The United States District Court for the District of Massachusetts recently granted, in part, a motion for summary judgment in Powers v. Receivables Performance Management, LLC limiting the plaintiff's damages in her Chapter 93A case to nominal damages. No. 4:21-cv-12125-MRG, 2025 LX 444693 (D. Mass. Sep. 25, 2025).

During a recent webinar, the New Mexico Environment Department (NMED) announced plans to propose a rule that will impose an unprecedented labeling requirements on all products containing intentionally...

On Sept. 23, 2025, the California Privacy Protection Agency (CPPA) announced that the state's Office of Administrative Law (OAL) had formally approved the CPPA's wide-ranging package...

The Federal Trade Commission once again signaled its continued focus on making it easy to cancel recurring charges and avoid misleading practices in negative option plans.

A federal district court ruled that the Education Department violated the Administrative Procedure Act and the U.S. Constitution by improperly issuing guidance that deemed...

Sectoral tariffs are emerging as a preferred tool for the White House that leaves targeted industries, and those reliant on their import supply, subject to appreciably higher customs duties on imported goods.

POM Wonderful v FTC - Both Sides Claim Victory even though the Court says: "neither side’s position as to the claims made or adequacy of substantiation has been totally vindicated."

On May 30, 2012, the public comment period began for proposed regulations issued by thirteen New York State agencies (including the Department of Health, the Office of Mental Health, and the Office of Children and Family Services) seeking to limit the executive compensation paid by, and administrative costs of, service providers that receive State funding.

On May 21, 2012, the Ninth Circuit Court of Appeals held that because the use of medical marijuana remains illegal under federal law, the Americans with Disabilities Act (ADA) does not protect against discrimination on the basis of medical marijuana use, even if that use is in accordance with state law explicitly authorizing such use.

Between Q1 and Q2 of 2025, supply chain indicators showed differing signals across sectors. Inventory turnover improved in most categories, with notable gains in Home & Outdoor and Durables, suggesting better inventory...

On September 12, 2025, the U.S. Food and Drug Administration (FDA) announced the launch of the FDA Adverse Event Reporting System (FAERS) Public Dashboard for Cosmetic Products.

The product identification process presently under way in the Aqueous Film-Forming Foam (AFFF) multidistrict litigation (MDL) offers an innovative application of discovery practices...